604 related articles for article (PubMed ID: 18209726)
21. Hematopoietic stem cell transplantation in adults with acute myeloid leukemia.
Hamadani M; Awan FT; Copelan EA
Biol Blood Marrow Transplant; 2008 May; 14(5):556-67. PubMed ID: 18410898
[TBL] [Abstract][Full Text] [Related]
22. Reduced-intensity cord blood transplantation without prior remission induction therapy induces durable remission in adult patients with relapsed acute leukemia after the first allogeneic transplantation.
Ueki T; Sumi M; Sato K; Shimizu I; Akahane D; Ueno M; Ichikawa N; Nakao S; Kobayashi H
Eur J Haematol; 2011 Mar; 86(3):268-71. PubMed ID: 21114536
[No Abstract] [Full Text] [Related]
23. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
24. Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
Bachanova V; Weisdorf D
Bone Marrow Transplant; 2008 Mar; 41(5):455-64. PubMed ID: 17968329
[TBL] [Abstract][Full Text] [Related]
25. Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.
Champlin R; Khouri I; Anderlini P; Gajewski J; Kornblau S; Molldrem J; Shimoni A; Ueno N; Giralt S
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S13-22. PubMed ID: 11436116
[TBL] [Abstract][Full Text] [Related]
26. Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
Ringdén O; Labopin M; Ehninger G; Niederwieser D; Olsson R; Basara N; Finke J; Schwerdtfeger R; Eder M; Bunjes D; Gorin NC; Mohty M; Rocha V
J Clin Oncol; 2009 Sep; 27(27):4570-7. PubMed ID: 19652066
[TBL] [Abstract][Full Text] [Related]
27. Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.
Sengsayadeth S; Savani BN; Blaise D; Malard F; Nagler A; Mohty M
Haematologica; 2015 Jul; 100(7):859-69. PubMed ID: 26130513
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic transplantation for ALL in adults.
Stein A; Forman SJ
Bone Marrow Transplant; 2008 Mar; 41(5):439-46. PubMed ID: 18334992
[TBL] [Abstract][Full Text] [Related]
29. [Allogeneic stem cell transplantation in the management of acute myeloid leukemia].
Schmid C; Kolb HJ
Med Klin (Munich); 2007 Apr; 102(4):317-23. PubMed ID: 17426935
[TBL] [Abstract][Full Text] [Related]
30. High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML.
O'Meara A; Pabst T; Heim D; Gerull S; Bucher C; Halter J; Arber C; Rovò A; Tichelli A; Gratwohl A; Stern M
Bone Marrow Transplant; 2011 May; 46(5):636-40. PubMed ID: 20697364
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
32. Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up.
Shimoni A; Hardan I; Shem-Tov N; Yerushalmi R; Nagler A
Leukemia; 2010 May; 24(5):1050-2. PubMed ID: 20147978
[No Abstract] [Full Text] [Related]
33. Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.
Aversa F
Bone Marrow Transplant; 2008 Mar; 41(5):473-81. PubMed ID: 18176612
[TBL] [Abstract][Full Text] [Related]
34. Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
Oran B; Giralt S; Couriel D; Hosing C; Shpall EJ; de Meis E; Khouri IF; Qazilbash M; Anderlini P; Kebriaei P; Popat U; Carrasco-Yalan A; Champlin RE; de Lima M
Leukemia; 2007 Dec; 21(12):2540-4. PubMed ID: 17611563
[No Abstract] [Full Text] [Related]
35. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Barosi G; Bacigalupo A
Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.
Sierra J; Martino R; Sánchez B; Piñana JL; Valcárcel D; Brunet S
Bone Marrow Transplant; 2008 Mar; 41(5):425-37. PubMed ID: 18209727
[TBL] [Abstract][Full Text] [Related]
37. Reduced-intensity allogeneic stem cell transplantation.
Bearman SI
Curr Hematol Rep; 2003 Jul; 2(4):277-86. PubMed ID: 12901324
[TBL] [Abstract][Full Text] [Related]
38. Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia.
Petersen FB; Ford CD
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S7-9. PubMed ID: 19561415
[TBL] [Abstract][Full Text] [Related]
39. [Results of hematopoietic cell transplantation in the first complete remission in children with acute myeloid leukemia from an intermediate risk group].
SDyshlevaia ZM; Skorobogatova EV; Maschan MA; Shipitsyna IP; Skvortsova IuV; Trakhtman PE; Balashov DN; Pashko IuV; Kurnikova EE; Suntsova EV; Goronkova OV; Solopova GG; Baĭdil'dina DD; Kalinina II; Khachatrian LA; Shneĭder MM; Maschan AA
Ter Arkh; 2010; 82(7):34-40. PubMed ID: 20853607
[TBL] [Abstract][Full Text] [Related]
40. Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia.
Cordonnier C; Maury S; Esperou H; Pautas C; Beaune J; Rodet M; Lagrange JL; Rouard H; Beaumont JL; Bassompierre F; Glückman E; Kuentz M; Durand-Zaleski I
Bone Marrow Transplant; 2005 Oct; 36(7):649-54. PubMed ID: 16044135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
